Targeting Venetoclax Resistance in TP53-Mutated Acute Myeloid Leukemia

被引：0
|
作者：
Vanttinen, Ida [1 ,2 ]
Ruokoranta, Tanja [1 ]
Saad, Joseph J. [1 ,2 ]
Kytola, Sari [3 ]
Hellesoy, Monica [4 ]
Gullaksen, Stein-Erik [4 ]
Ettala, Pia-Sofia [5 ]
Pyorala, Marja [6 ]
Rimpilainen, Johanna [7 ]
Siitonen, Timo [8 ]
Wennerberg, Krister [9 ]
Gjertsen, Bjorn T. [4 ,10 ]
Heckman, Caroline A. [1 ,2 ]
Kontro, Mika [1 ,2 ,3 ,11 ]
Kuusanmaki, Heikki [1 ,2 ,9 ,11 ]
机构：
[1] Univ Helsinki, Inst Mol Med Finland FIMM, HiLIFE, Helsinki, Finland
[2] ICAN Digital Precis Canc Med Flagship, Helsinki, Finland
[3] Helsinki Univ Hosp, Dept Hematol, Comprehens Canc Ctr, Helsinki, Finland
[4] Helse Bergen, Hematol Sect, Dept Med, Bergen, Norway
[5] Turku Univ Hosp, Dept Clin Hematol, Turku, Finland
[6] Kuopio Univ Hosp, Dept Med, Kuopio, Finland
[7] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland
[8] Oulu Univ Hosp, Canc Ctr, Hematol, Oulu, Finland
[9] Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, Copenhagen, Denmark
[10] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway
[11] Fdn Finnish Canc Inst, Helsinki, Finland
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189340
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [1] TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
    Testa, Ugo
    Castelli, Germana
    Pelosi, Elvira
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)
  • [2] Targeting TP53-Mutated Acute Myeloid Leukemia: Research and Clinical Developments
    Granowicz, Eric M.
    Jonas, Brian A.
    ONCOTARGETS AND THERAPY, 2022, 15 : 423 - 436
  • [3] Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia
    Aldoss, Ibrahim
    Zhang, Jianying
    Pillai, Raju
    Shouse, Geoffrey
    Sanchez, James F.
    Mei, Matthew
    Nakamura, Ryotaro
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) : E45 - E48
  • [4] Activity of venetoclax-based therapy in TP53-mutated acute myeloid leukemia.
    Shoukier, Mahran
    Konopleva, Marina
    Dinardo, Courtney Denton
    Ravandi, Farhad
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Daver, Naval Guastad
    Borthakur, Gautam
    Pemmaraju, Naveen
    Montalban-Bravo, Guillermo
    Benton, Christopher Brent
    Short, Nicholas James
    Bhalla, Kapil N.
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Precision medicine for TP53-mutated acute myeloid leukemia
    Brattas, Marte Karen
    Reikvam, Hakon
    Tvedt, Tor Henrik Anderson
    Bruserud, Oystein
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (05): : 263 - 274
  • [6] Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting cell cycle checkpoint
    Gwak, Daehyeon
    Kim, Dongchan
    Jang, Heejun
    Liu, Jun
    Min, Suji
    Byun, Ja Min
    Koh, Youngil
    Hong, Junshik
    Yoon, Sung-Soo
    Shin, Dong-Yeop
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Are We Moving the Needle for Patients with TP53-Mutated Acute Myeloid Leukemia?
    Shallis, Rory M.
    Bewersdorf, Jan P.
    Stahl, Maximilian F.
    Halene, Stephanie
    Zeidan, Amer M.
    CANCERS, 2022, 14 (10)
  • [8] Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
    Wang, Yin
    Liu, Yan
    Bailey, Christopher
    Zhang, Huixia
    He, Miao
    Sun, Duxin
    Zhang, Peng
    Parkin, Brian
    Baer, Maria R.
    Zheng, Pan
    Malek, Sami N.
    Liu, Yang
    ONCOGENE, 2020, 39 (14) : 3015 - 3027
  • [9] Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
    Yin Wang
    Yan Liu
    Christopher Bailey
    Huixia Zhang
    Miao He
    Duxin Sun
    Peng Zhang
    Brian Parkin
    Maria R. Baer
    Pan Zheng
    Sami N. Malek
    Yang Liu
    Oncogene, 2020, 39 : 3015 - 3027
  • [10] Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia
    Boddu, Prajwal
    Kantarjian, Hagop
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Andreeff, Michael
    Jabbour, Elias J.
    Benton, Christopher B.
    DiNardo, Courtney D.
    Konopleva, Marina
    Daver, Naval
    Patel, Keyur
    Takahashi, Koichi
    Kanagal-Shamanna, Rashmi
    Cortes, Jorge
    Kadia, Tapan
    LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2238 - 2241
12345